Results 131 to 140 of about 44,133 (142)

Finasteride and the 5-Alpha Reductase Inhibitors

Bilal F. Hamzeh, Haley Guinan, Julyssa A. Renteria, Robert Dorfman   +3 more
openaire   +1 more source

Alpha‐1 adrenergic antagonists, 5‐alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta‐analysis of urodynamic studies

Neurourology and Urodynamics, 2018
Enrico Finazzi Agro, Cosimo De Nunzio, Ferdinando Fusco   +2 more
exaly  

Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors

European Urology, 2007
Geraldine Cancel-Tassin, Olivier Cussenot, Antoine Valeri   +2 more
exaly  

Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation

Expert Opinion on Drug Safety, 2013
Serap Gur
exaly  

[Alpha blockers and 5-alpha reductase inhibitors].

Pharmazie in unserer Zeit, 2008
Ulrike, Holzgrabe, Andrea, Sinz
openaire   +1 more source

Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: Effect of 5-alpha reductase inhibitors

Prostate, 1995
exaly  

Establishing the clinical and economic benefits of adherence to 5-alpha reductase inhibitors in benign prostatic hyperplasia: an assessment of Medicare and Medicaid patients

Expert Opinion on Pharmacotherapy, 2012
exaly  

5-alpha-reductase inhibitors for prostate cancer prevention

The Cochrane Library
, Barnett S Kramer, Roderick Macdonald
exaly  

[5-alpha reductase inhibitor in prostatic adenoma?].

Medizinische Monatsschrift fur Pharmazeuten, 1991
openaire   +1 more source

Approaches to prostatic 5 alpha-reductase inhibitors.

Progress in clinical and biological research, 1982
openaire   +1 more source